EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GnT-V-mediated aberrant N-glycosylation of TIMP-1 promotes diabetic retinopathy progression

Xiaoting Xi, Yanni Yang, Qianbo Chen, Jia Ma, Xuewei Wang, Yachun Deng, Xi Wang, Yan Li

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09388-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Xiaoting Xi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, The First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming, 650032, Yunnan, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Retinopathy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Province Applied Basic Research (Kunming Medical University Joint Project), The scientific research project of the internal research institution in the medical and health unit of Yunnan Province, Funded by Bethune Langmu Young and Middle-aged Eye Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vascular endothelial growth factor (VEGF) signaling pathway plays an important role in the progression of diabetic retinopathy (DR). The glycosylation modification process of many key functional proteins in DR patients is abnormal. However, the potential involvement of abnormal N-glycoproteins in DR progression remains unclear.

Methods

Glycoproteomic profiling of the vitreous humor was performed. The level of protein and N-glycoprotein was confirmed by Western blot and Lectin blot, respectively. The cell viability and migration efficiency were detected by CCK-8 and Transwell assay. Flow cytometry was conducted to analyze the level of cell apoptosis and reactive oxygen specie. Malondialdehyde, superoxide dismutase activity and VEGF content were detected by Enzyme linked immunosorbent assays. The interaction of metalloproteinase 1 (TIMP-1) with N-acetylglucosamine transferase V (GnT-V) was detected by GST pull-down. Hematoxylin and eosin staining and choroidal and retinal flat mount stained with fluorescein isothiocyanate-Dextran assay were used for functional research in vivo.

Results

We found that N-glycosylation was up-regulated in DR rats and high glucose (HG)-induced human retinal pigment epithelium cell line ARPE-19. HG-induced inhibited the viability of ARPE-19 cells and promoted cell apoptosis and oxidative stress (OS), but these effects were reversed with kifunensine treatment, GnT-V knockdown and TIMP-1 mutation. Additionally, GnT-V binds to TIMP-1 to promote N-glycosylation of TIMP-1. Over-expression of GnT-V inhibited the viability of ARPE-19 cells and promoted cell apoptosis, OS and VEGF release, which these effects were reversed with TIMP-1 mutation. Interestingly, over-expression of GnT-V promoted retinal microvascular endothelial cells (RMECs) angiogenesis but was revered with TIMP-1 mutation, which was terminally boosted by VEGF-A treatment. Finally, knockdown of GnT-V relieved DR progression.

Conclusion

The findings indicate that GnT-V can promote RMECs angiogenesis and ARPE-19 cells injury through activation VEGF signaling pathway by increasing TIMP-1 N-glycosylation level, which provides a new theoretical basis for the prevention of DR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDiabetic RetinopathyAnimalsHumansRatsCell MovementEndothelial CellsGlucoseGlycosylationTissue Inhibitor of Metalloproteinase-1Vascular Endothelial Growth Factor AN-Acetylglucosaminyltransferases

Stichwörter der Autor:innen

Diabetic retinopathyN-acetylglucosaminyltransferase VN-glycosylationTissue inhibitor of metalloproteinase 1Vascular endothelial growth factor

Substanzen

GlucoseTissue Inhibitor of Metalloproteinase-1Vascular Endothelial Growth Factor AMgat5 protein, humanN-AcetylglucosaminyltransferasesTIMP1 protein, ratTIMP1 protein, human

Autor:innen und Institutionen

  • Ophthalmology Department, The First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming, 650032, Yunnan, China.
  • Ophthalmology Department, The Second Hospital of Ningbo, Ningbo, 315010, Zhejiang, China.
  • Ophthalmology Department, The First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming, 650032, Yunnan, China. li_yan_km@163.com.

Förderung

  • Yunnan Province Applied Basic Research (Kunming Medical University Joint Project)
  • The scientific research project of the internal research institution in the medical and health unit of Yunnan Province
  • Funded by Bethune Langmu Young and Middle-aged Eye Research Fund
  • Kunming Medical University Doctoral Innovation Fund Project
  • National Natural Science Foundation of China Regional Project
  • The Doctoral Research Fund Project of the First Affiliated Hospital of Kunming Medical University

Zitieren

APA

Xi, X., Yang, Y., Chen, Q., Ma, J., Wang, X., Deng, Y., Wang, X., & Li, Y. (2024). GnT-V-mediated aberrant N-glycosylation of TIMP-1 promotes diabetic retinopathy progression. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09388-7

Vancouver

Xi X, Yang Y, Chen Q, Ma J, Wang X, Deng Y, et al. GnT-V-mediated aberrant N-glycosylation of TIMP-1 promotes diabetic retinopathy progression. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09388-7

BibTeX
@article{Xi2024,
  author = {Xi, Xiaoting and Yang, Yanni and Chen, Qianbo and Ma, Jia and Wang, Xuewei and Deng, Yachun and Wang, Xi and Li, Yan},
  title = {GnT-V-mediated aberrant N-glycosylation of TIMP-1 promotes diabetic retinopathy progression},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09388-7}
}
Kostenlos starten →